222 related articles for article (PubMed ID: 24417479)
1. Synthesis and biological evaluation of novel tetrahydro-β-carboline derivatives as antitumor growth and metastasis agents through inhibiting the transforming growth factor-β signaling pathway.
Zheng C; Fang Y; Tong W; Li G; Wu H; Zhou W; Lin Q; Yang F; Yang Z; Wang P; Peng Y; Pang X; Yi Z; Luo J; Liu M; Chen Y
J Med Chem; 2014 Feb; 57(3):600-12. PubMed ID: 24417479
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
Fang Y; Chen Y; Yu L; Zheng C; Qi Y; Li Z; Yang Z; Zhang Y; Shi T; Luo J; Liu M
J Natl Cancer Inst; 2013 Jan; 105(1):47-58. PubMed ID: 23178439
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives.
Cao R; Chen H; Peng W; Ma Y; Hou X; Guan H; Liu X; Xu A
Eur J Med Chem; 2005 Oct; 40(10):991-1001. PubMed ID: 15950325
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxic activity of novel quinazolino-beta-carboline-5-one derivatives.
Baruah B; Dasu K; Vaitilingam B; Mamnoor P; Venkata PP; Rajagopal S; Yeleswarapu KR
Bioorg Med Chem; 2004 May; 12(9):1991-4. PubMed ID: 15080902
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines.
Shi B; Cao R; Fan W; Guo L; Ma Q; Chen X; Zhang G; Qiu L; Song H
Eur J Med Chem; 2013 Feb; 60():10-22. PubMed ID: 23279863
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents.
Chen YF; Lin YC; Chen JP; Chan HC; Hsu MH; Lin HY; Kuo SC; Huang LJ
Bioorg Med Chem Lett; 2015 Sep; 25(18):3873-7. PubMed ID: 26235951
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure--activity relationships of N²-alkylated quaternary β-carbolines as novel antitumor agents.
Zhang G; Cao R; Guo L; Ma Q; Fan W; Chen X; Li J; Shao G; Qiu L; Ren Z
Eur J Med Chem; 2013 Jul; 65():21-31. PubMed ID: 23688697
[TBL] [Abstract][Full Text] [Related]
8. Syntheses of novel β-carboline derivatives and the activities against five tumor-cell lines.
Bai B; Li XY; Liu L; Li Y; Zhu HJ
Bioorg Med Chem Lett; 2014 Jan; 24(1):96-8. PubMed ID: 24345445
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of β-carboline 3-(substituted-carbohydrazide) derivatives.
Barbosa VA; Formagio AS; Savariz FC; Foglio MA; Spindola HM; de Carvalho JE; Meyer E; Sarragiotto MH
Bioorg Med Chem; 2011 Nov; 19(21):6400-8. PubMed ID: 21944971
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro anti-inflammatory and cytotoxic evaluation, and mechanism of action studies of 1-benzoyl-β-carboline and 1-benzoyl-3-carboxy-β-carboline derivatives.
Yang ML; Kuo PC; Hwang TL; Chiou WF; Qian K; Lai CY; Lee KH; Wu TS
Bioorg Med Chem; 2011 Mar; 19(5):1674-82. PubMed ID: 21316977
[TBL] [Abstract][Full Text] [Related]
11. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxic activities of beta-carboline amino acid ester conjugates.
Zhao M; Bi L; Wang W; Wang C; Baudy-Floc'h M; Ju J; Peng S
Bioorg Med Chem; 2006 Oct; 14(20):6998-7010. PubMed ID: 16806943
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel β-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance.
Li Y; Yan W; Yang J; Yang Z; Hu M; Bai P; Tang M; Chen L
Eur J Med Chem; 2018 May; 152():516-526. PubMed ID: 29754076
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
Chen Z; Cao R; Shi B; Yi W; Yu L; Song H; Ren Z; Peng W
Bioorg Med Chem Lett; 2010 Jul; 20(13):3876-9. PubMed ID: 20627721
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of asymmetric dimeric β-carboline derivatives as potential antitumor agents.
Guo L; Chen W; Cao R; Fan W; Ma Q; Zhang J; Dai B
Eur J Med Chem; 2018 Mar; 147():253-265. PubMed ID: 29448140
[TBL] [Abstract][Full Text] [Related]
17. Design of beta-carboline derivatives as DNA-targeting antitumor agents.
Guan H; Chen H; Peng W; Ma Y; Cao R; Liu X; Xu A
Eur J Med Chem; 2006 Oct; 41(10):1167-79. PubMed ID: 16790297
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anticancer evaluation of tetrahydro-β-carboline-hydantoin hybrids.
Shankaraiah N; Nekkanti S; Chudasama KJ; Senwar KR; Sharma P; Jeengar MK; Naidu VG; Srinivasulu V; Srinivasulu G; Kamal A
Bioorg Med Chem Lett; 2014 Dec; 24(23):5413-7. PubMed ID: 25453799
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis and antitumor activities of 1-(4-chlorophenyl)-beta-carboline derivatives].
Ma Q; Guo L; Sun J; Fan WX
Yao Xue Xue Bao; 2013 Jan; 48(1):77-82. PubMed ID: 23600145
[TBL] [Abstract][Full Text] [Related]
20. Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line.
Ehata S; Hanyu A; Fujime M; Katsuno Y; Fukunaga E; Goto K; Ishikawa Y; Nomura K; Yokoo H; Shimizu T; Ogata E; Miyazono K; Shimizu K; Imamura T
Cancer Sci; 2007 Jan; 98(1):127-33. PubMed ID: 17129361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
